THE INHIBITION OF MONOAMINE OXIDASE BY BENZYL AND PHENETHYLGUANIDINES RELATED TO BRETYLIUM AND GUANETHIDINE
- 1 July 1963
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 107 (3), 945-950
- https://doi.org/10.1111/j.1749-6632.1963.tb13337.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A CLINICAL TRIAL OF TWO RELATED ADRENERGIC-NEURONE-BLOCKING AGENTS—B.W. 392C60 AND B.W. 467C60The Lancet, 1962
- The inhibition of monoamine oxidase by arylalkylhydrazinesBiochemical Journal, 1962
- Structural requirements for bretylium and guanethidine-like activity in a series of guanidine derivativesLife Sciences, 1962
- Adrenergic Neurone-blocking Agents related to Choline 2,6-Xylyl Ether Bromide (TM 10), Bretylium and GuanethidineNature, 1961
- Monoamine Oxidase Inhibitors and Procedures for their Evaluation In Vivo and In VitroJournal of Medicinal Chemistry, 1960
- The interaction between reversible and irreversible monoamine oxidase inhibitorsBiochemical Pharmacology, 1960
- THE DISTRIBUTION OF SEROTONIN, 5‐HYDROXYTRYPTOPHAN DECARBOXYLASE, AND MONOAMINE OXIDASE IN BRAIN*Journal of Neurochemistry, 1957
- AMINE OXIDASESPublished by Elsevier ,1955